Matches in Wikidata for { <http://www.wikidata.org/entity/Q37687748> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q37687748 description "article científic" @default.
- Q37687748 description "article scientifique" @default.
- Q37687748 description "articolo scientifico" @default.
- Q37687748 description "artigo científico" @default.
- Q37687748 description "artículu científicu espublizáu en 2010" @default.
- Q37687748 description "bilimsel makale" @default.
- Q37687748 description "scientific article published on 04 February 2010" @default.
- Q37687748 description "vedecký článok" @default.
- Q37687748 description "vetenskaplig artikel" @default.
- Q37687748 description "videnskabelig artikel" @default.
- Q37687748 description "vědecký článek" @default.
- Q37687748 description "wetenschappelijk artikel" @default.
- Q37687748 description "wissenschaftlicher Artikel" @default.
- Q37687748 description "наукова стаття, опублікована в лютому 2010" @default.
- Q37687748 description "научни чланак" @default.
- Q37687748 description "مقالة علمية نشرت في 04 فبراير 2010" @default.
- Q37687748 name "The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?" @default.
- Q37687748 name "The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?" @default.
- Q37687748 name "The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?" @default.
- Q37687748 type Item @default.
- Q37687748 label "The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?" @default.
- Q37687748 label "The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?" @default.
- Q37687748 label "The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?" @default.
- Q37687748 prefLabel "The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?" @default.
- Q37687748 prefLabel "The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?" @default.
- Q37687748 prefLabel "The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?" @default.
- Q37687748 P1433 Q37687748-AF27E063-19FA-4DB8-AC84-0ADFBCF1A8F1 @default.
- Q37687748 P1476 Q37687748-D2718E7D-2FBA-4CC8-974A-60F59AAF4C3E @default.
- Q37687748 P2093 Q37687748-2B018C98-6946-4044-97F8-A8692A55F41F @default.
- Q37687748 P304 Q37687748-9881EE71-D58A-4188-8E3B-652318B778E3 @default.
- Q37687748 P31 Q37687748-65478547-3A8C-4099-B6C9-37E52903A52C @default.
- Q37687748 P31 Q37687748-eb730ab9-1636-4ec4-a328-84a44b7f0af5 @default.
- Q37687748 P356 Q37687748-02B5749A-16C7-4824-8BC7-BDD406BF8DA3 @default.
- Q37687748 P433 Q37687748-C6BFAEC0-F63F-4FC0-A33F-588CC9BD2525 @default.
- Q37687748 P478 Q37687748-2A40BDD6-FBA2-40AF-A864-DF16B2A097C0 @default.
- Q37687748 P577 Q37687748-6EE0A412-DF9C-4147-98CE-72EA1B0DFB65 @default.
- Q37687748 P698 Q37687748-5AD2B204-AAE3-452A-A66B-113B82E3B936 @default.
- Q37687748 P921 Q37687748-5C997884-AC7F-43D5-8DAE-25777771A88A @default.
- Q37687748 P356 JPHS.09R15FM @default.
- Q37687748 P698 20134112 @default.
- Q37687748 P1433 Q15766064 @default.
- Q37687748 P1476 "The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?" @default.
- Q37687748 P2093 "Martin C Michel" @default.
- Q37687748 P304 "151-157" @default.
- Q37687748 P31 Q13442814 @default.
- Q37687748 P31 Q7318358 @default.
- Q37687748 P356 "10.1254/JPHS.09R15FM" @default.
- Q37687748 P433 "2" @default.
- Q37687748 P478 "112" @default.
- Q37687748 P577 "2010-02-04T00:00:00Z" @default.
- Q37687748 P698 "20134112" @default.
- Q37687748 P921 Q1135939 @default.